ATRA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 3.70%

Insider Buying (Last 12 Months): $64,380.00

Insider Selling (Last 12 Months): $215,022.75

Atara Biotherapeutics Insider Trading History Chart

Atara Biotherapeutics Share Price & Price History

^$10.17

▲ +0.41 (4.20%)

As of 07/26/2024 01:00 AM ET

Days: 30 | 90 | 365

Nvidia’s Quiet $1 Trillion Pivot

From Weiss Ratings | Ad

Nvidia recently added $277 billion in market cap … IN ONE DAY.

Find out details on these three critical Nvidia partners immediately.

Atara Biotherapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
5/16/2024	Anhco Nguyen	EVP	Sell	1,715	$15.50	$26,582.50	35,939
5/16/2024	Eric J Hyllengren	CFO	Sell	1,145	$15.50	$17,747.50	25,826
5/16/2024	Pascal Touchon	CEO	Sell	3,260	$15.50	$50,530.00	73,165
3/4/2024	Anhco Nguyen	EVP	Sell	429	$18.00	$7,722.00	37,655
3/4/2024	Pascal Touchon	CEO	Sell	993	$18.00	$17,874.00	76,426
11/16/2023	Anhco Nguyen	EVP	Sell	354	$9.75	$3,451.50	11,085
11/16/2023	Eric J Hyllengren	CFO	Sell	478	$9.75	$4,660.50	8,239
11/16/2023	Pascal Touchon	CEO	Sell	816	$9.75	$7,956.00	26,219
11/13/2023	Carol Giltner Gallagher	Director	Buy	7,160	$5.50	$39,380.00	14,737
11/10/2023	William K Heiden	Director	Buy	4,000	$6.25	$25,000.00	8,360
8/16/2023	K. Amar Murugan	EVP	Sell	346	$41.25	$14,272.50	10,615
8/16/2023	Eric J Hyllengren	CFO	Sell	327	$41.25	$13,488.75	8,718
8/16/2023	Pascal Touchon	CEO	Sell	1,230	$41.25	$50,737.50	27,036
6/27/2023	Pascal Touchon	CEO	Sell	571	$41.50	$23,696.50	28,266
5/16/2023	K. Amar Murugan	EVP	Sell	335	$51.00	$17,085.00	10,837
5/16/2023	Eric J Hyllengren	CFO	Sell	316	$51.00	$16,116.00	9,045
5/16/2023	Pascal Touchon	CEO	Sell	1,190	$51.00	$60,690.00	28,838
3/2/2023	K. Amar Murugan	SVP	Sell	168	$90.75	$15,246.00	11,173
3/2/2023	Jakob Dupont	EVP	Sell	202	$90.75	$18,331.50	11,631
3/2/2023	Pascal Touchon	CEO	Sell	627	$90.75	$56,900.25	30,029
3/2/2023	Utpal Koppikar	CFO	Sell	274	$90.75	$24,865.50	7,279
2/7/2023	Utpal Koppikar	CFO	Sell	99	$136.50	$13,513.50	7,553
11/16/2022	K. Amar Murugan	SVP	Sell	144	$112.25	$16,164.00	5,103
11/16/2022	Jakob Dupont	EVP	Sell	173	$112.25	$19,419.25	6,181
11/16/2022	Pascal Touchon	CEO	Sell	623	$112.25	$69,931.75	17,667
11/16/2022	Utpal Koppikar	CFO	Sell	250	$112.25	$28,062.50	7,653
8/16/2022	K. Amar Murugan	SVP	Sell	137	$125.75	$17,227.75	5,247
8/16/2022	Jakob Dupont	EVP	Sell	164	$125.75	$20,623.00	6,355
8/16/2022	Pascal Touchon	CEO	Sell	592	$126.00	$74,592.00	18,291
8/16/2022	Utpal Koppikar	CFO	Sell	237	$126.00	$29,862.00	7,903
6/27/2022	Pascal Touchon	CEO	Sell	568	$180.00	$102,240.00	18,883
5/17/2022	K. Amar Murugan	SVP	Sell	128	$133.00	$17,024.00	5,349
5/17/2022	Jakob Dupont	EVP	Sell	154	$133.00	$20,482.00	6,520
5/17/2022	Pascal Touchon	CEO	Sell	556	$133.00	$73,948.00	19,452
5/17/2022	Utpal Koppikar	CFO	Sell	223	$133.00	$29,659.00	8,303
2/10/2022	Jakob Dupont	EVP	Sell	200	$400.00	$80,000.00
2/7/2022	Utpal Koppikar	CFO	Sell	99	$361.50	$35,788.50
11/16/2021	K. Amar Murugan	SVP	Sell	84	$428.00	$35,952.00
11/16/2021	Jakob Dupont	EVP	Sell	87	$428.00	$37,236.00
11/16/2021	Pascal Touchon	CEO	Sell	336	$428.00	$143,808.00
11/16/2021	Utpal Koppikar	CFO	Sell	146	$428.00	$62,488.00
11/15/2021	Joe Newell	Insider	Sell	280	$442.75	$123,970.00
11/4/2021	Matthew K. Fust	Director	Sell	534	$487.50	$260,325.00
11/2/2021	Jakob Dupont	EVP	Sell	200	$410.25	$82,050.00
9/22/2021	Joe Newell	Insider	Sell	420	$425.00	$178,500.00
8/30/2021	Joe Newell	Insider	Sell	140	$375.00	$52,500.00	4,921
8/17/2021	K. Amar Murugan	SVP	Sell	83	$313.25	$25,999.75	3,586
8/17/2021	Jakob Dupont	EVP	Sell	86	$313.25	$26,939.50	3,711
8/17/2021	Joe Newell	Insider	Sell	97	$313.25	$30,385.25	5,061
8/17/2021	Pascal Touchon	CEO	Sell	328	$313.25	$102,746.00	13,475
8/17/2021	Utpal Koppikar	CFO	Sell	143	$313.25	$44,794.75	6,454

J.P. Morgan’s DIRE Warning

From Behind the Markets | Ad

When the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal warns, "America's bonds are getting harder to sell."

Click here to see why Wall Street is in PANIC mode >>>

SEC Filings (Institutional Ownership Changes) for Atara Biotherapeutics (NASDAQ:ATRA)

70.90% of Atara Biotherapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Atara Biotherapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/16/2024	Redmile Group LLC	9,263,309	$6.43M	0.2%	+1.7%	7.693%
5/15/2024	Price T Rowe Associates Inc. MD	4,958,150	$3.44M	0.0%	+8,916.3%	4.117%
5/14/2024	Delap Wealth Advisory LLC	41,533	$29K	0.0%	N/A	0.034%
5/10/2024	Acadian Asset Management LLC	2,638,687	$1.83M	0.0%	+49.5%	2.191%
5/10/2024	Vanguard Group Inc.	5,012,938	$3.48M	0.0%	-25.0%	4.163%
5/1/2024	BNP Paribas Financial Markets	383,082	$0.27M	0.0%	+29.3%	0.318%
1/30/2024	Vontobel Holding Ltd.	80,000	$41K	0.0%	N/A	0.078%
1/8/2024	Harbor Capital Advisors Inc.	208,827	$0.11M	0.0%	+368.0%	0.205%
12/6/2023	Citigroup Inc.	453,102	$0.67M	0.0%	-5.9%	0.445%
11/22/2023	Josh Arnold Investment Consultant LLC	200,000	$0.30M	0.3%	+17.6%	0.196%
11/15/2023	Redmile Group LLC	6,280,813	$9.30M	0.4%	+3.8%	6.162%
11/14/2023	683 Capital Management LLC	1,200,000	$1.78M	0.1%	+20.0%	1.177%
11/14/2023	Staley Capital Advisers Inc.	1,000,000	$1.48M	0.1%	+33.3%	0.981%
11/13/2023	Acadian Asset Management LLC	534,393	$0.79M	0.0%	-24.2%	0.524%
11/9/2023	Deutsche Bank AG	388,384	$0.58M	0.0%	-43.6%	0.381%
11/3/2023	Private Advisor Group LLC	95,463	$0.14M	0.0%	+53.0%	0.094%
10/27/2023	Hennion & Walsh Asset Management Inc.	168,916	$0.25M	0.0%	-5.7%	0.167%
10/27/2023	Allspring Global Investments Holdings LLC	38,967	$58K	0.0%	-41.3%	0.039%
10/24/2023	Pinnacle Associates Ltd.	385,364	$0.57M	0.0%	-2.6%	0.381%
10/13/2023	SG Americas Securities LLC	38,743	$57K	0.0%	N/A	0.038%
9/21/2023	Barclays PLC	35,353	$56K	0.0%	-91.2%	0.035%
8/14/2023	683 Capital Management LLC	1,000,000	$1.61M	0.1%	N/A	0.989%
8/14/2023	Graham Capital Management L.P.	85,672	$0.14M	0.0%	N/A	0.085%
8/11/2023	Baupost Group LLC MA	9,773,616	$15.74M	0.3%	+7.1%	9.667%
8/11/2023	B. Metzler seel. Sohn & Co. AG	98,564	$0.16M	0.0%	+100.0%	0.097%
8/11/2023	ExodusPoint Capital Management LP	417,882	$0.67M	0.0%	+52.8%	0.427%
8/10/2023	Private Advisor Group LLC	62,400	$100K	0.0%	N/A	0.064%
8/8/2023	Wasatch Advisors LP	8,283,981	$13.34M	0.1%	-0.8%	8.456%
8/7/2023	Acadian Asset Management LLC	704,694	$1.13M	0.0%	N/A	0.719%
7/28/2023	Vanguard Personalized Indexing Management LLC	31,423	$51K	0.0%	N/A	0.032%
7/24/2023	Allspring Global Investments Holdings LLC	66,404	$0.11M	0.0%	+47.2%	0.068%
7/18/2023	Allspring Global Investments Holdings LLC	66,404	$0.11M	0.0%	+47.2%	0.068%
7/11/2023	Harbor Capital Advisors Inc.	50,076	$81K	0.0%	N/A	0.051%
5/12/2023	Baupost Group LLC MA	9,123,616	$26.46M	0.5%	+12.3%	9.442%
5/12/2023	Profund Advisors LLC	104,484	$0.30M	0.0%	N/A	0.108%
5/11/2023	ExodusPoint Capital Management LP	273,484	$0.79M	0.0%	+346.5%	0.283%
5/11/2023	Citigroup Inc.	911,219	$2.64M	0.0%	-11.1%	0.943%
5/11/2023	E Fund Management Co. Ltd.	32,062	$93K	0.0%	+21.7%	0.033%
5/5/2023	Pinnacle Associates Ltd.	399,316	$1.16M	0.0%	+1.6%	0.413%
5/4/2023	Barclays PLC	400,563	$1.16M	0.0%	+39.4%	0.415%
5/4/2023	Mirae Asset Global Investments Co. Ltd.	23,763	$69K	0.0%	-38.7%	0.025%
4/28/2023	SG Americas Securities LLC	34,707	$0.10M	0.0%	+29.0%	0.036%
4/20/2023	Hennion & Walsh Asset Management Inc.	269,146	$0.78M	0.0%	-2.9%	0.279%
4/14/2023	Raymond James & Associates	188,903	$0.55M	0.0%	+4.0%	0.195%
3/23/2023	MetLife Investment Management LLC	36,073	$0.12M	0.0%	-23.7%	0.038%
2/16/2023	Josh Arnold Investment Consultant LLC	52,000	$0.17M	0.3%	+73.3%	0.054%
2/14/2023	Alpine Global Management LLC	35,475	$0.12M	0.0%	N/A	0.037%
2/10/2023	M28 Capital Management LP	439,300	$1.44M	1.4%	N/A	0.463%
2/10/2023	Globeflex Capital L P	25,783	$85K	0.0%	N/A	0.027%
2/9/2023	Citigroup Inc.	1,025,418	$3.36M	0.0%	-20.5%	1.081%
2/8/2023	Swiss National Bank	193,700	$0.64M	0.0%	+3.9%	0.204%
2/8/2023	Oppenheimer & Co. Inc.	27,350	$90K	0.0%	-9.8%	0.029%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	61,994	$0.20M	0.0%	+26.7%	0.065%
2/2/2023	SG Americas Securities LLC	26,915	$88K	0.0%	-15.3%	0.028%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	13,469	$44K	0.0%	+27.5%	0.014%
2/1/2023	Pinnacle Associates Ltd.	393,198	$1.29M	0.0%	-1.3%	0.414%
1/25/2023	Pinnacle Associates Ltd.	418,873	$1.75M	0.0%	+5.1%	0.441%
1/23/2023	Allspring Global Investments Holdings LLC	45,699	$0.15M	0.0%	+19.7%	0.048%
1/12/2023	Hennion & Walsh Asset Management Inc.	277,201	$0.91M	0.1%	+12.5%	0.292%
11/15/2022	Bayesian Capital Management LP	43,341	$0.16M	0.0%	N/A	0.046%
11/15/2022	Caxton Associates LP	197,026	$0.75M	0.1%	+1,483.2%	0.208%
11/14/2022	Tudor Investment Corp Et Al	220,635	$0.83M	0.0%	+150.7%	0.233%
11/14/2022	683 Capital Management LLC	1,300,000	$4.91M	0.4%	-36.4%	1.370%
11/14/2022	Point72 Asset Management L.P.	30,000	$0.11M	0.0%	-99.2%	0.032%
11/14/2022	Lazard Asset Management LLC	11,922	$45K	0.0%	N/A	0.013%
11/14/2022	MetLife Investment Management LLC	47,290	$0.18M	0.0%	+12.3%	0.050%
11/14/2022	E Fund Management Co. Ltd.	36,673	$0.14M	0.0%	+43.1%	0.039%
11/14/2022	Cipher Capital LP	12,940	$49K	0.0%	N/A	0.014%
11/14/2022	Oppenheimer & Co. Inc.	30,314	$0.12M	0.0%	-11.8%	0.032%
11/14/2022	Hennion & Walsh Asset Management Inc.	246,383	$0.93M	0.1%	+7.8%	0.260%
11/10/2022	Connor Clark & Lunn Investment Management Ltd.	39,307	$0.15M	0.0%	-62.5%	0.042%
11/10/2022	ExodusPoint Capital Management LP	59,942	$0.23M	0.0%	N/A	0.064%
11/9/2022	SVB Wealth LLC	177,017	$0.67M	0.0%	N/A	0.188%
11/7/2022	Nisa Investment Advisors LLC	6,460	$28K	0.0%	+893.8%	0.007%
11/4/2022	Prudential Financial Inc.	42,938	$0.16M	0.0%	N/A	0.046%
11/4/2022	First Republic Investment Management Inc.	10,000	$38K	0.0%	N/A	0.011%
11/3/2022	Creative Planning	67,118	$0.25M	0.0%	+10.5%	0.071%
11/3/2022	Teacher Retirement System of Texas	25,843	$98K	0.0%	+113.7%	0.027%
11/3/2022	Barclays PLC	345,613	$1.31M	0.0%	+1,500.1%	0.366%
11/2/2022	Rockefeller Capital Management L.P.	53,936	$0.20M	0.0%	+24.2%	0.057%
11/2/2022	Daiwa Securities Group Inc.	11,261	$43K	0.0%	-20.9%	0.012%
11/1/2022	Pinnacle Associates Ltd.	398,414	$1.51M	0.0%	-7.1%	0.422%
10/31/2022	SG Americas Securities LLC	31,793	$0.12M	0.0%	-52.7%	0.034%
10/27/2022	US Bancorp DE	7,664	$29K	0.0%	+6,394.9%	0.008%
10/27/2022	Assenagon Asset Management S.A.	601,005	$2.27M	0.0%	-0.9%	0.637%
10/26/2022	Allspring Global Investments Holdings LLC	38,170	$0.14M	0.0%	+33.0%	0.040%
10/25/2022	Denali Advisors LLC	13,100	$50K	0.0%	N/A	0.014%
10/25/2022	Raymond James & Associates	184,338	$0.70M	0.0%	+182.6%	0.195%
10/24/2022	Wealth Architects LLC	13,277	$50K	0.0%	N/A	0.014%
10/14/2022	Diversified Trust Co	12,740	$48K	0.0%	N/A	0.014%
8/16/2022	Josh Arnold Investment Consultant LLC	30,000	$0.23M	0.3%	N/A	0.032%
8/16/2022	Caption Management LLC	52,000	$0.41M	0.0%	N/A	0.055%
8/15/2022	Eminence Capital LP	1,323,075	$10.31M	0.2%	-3.3%	1.402%
8/12/2022	Virtus ETF Advisers LLC	20,097	$0.16M	0.1%	+103.7%	0.021%
8/12/2022	Ensign Peak Advisors Inc	227,527	$1.77M	0.0%	+39.1%	0.241%
8/12/2022	B. Metzler seel. Sohn & Co. AG	16,121	$0.13M	0.0%	N/A	0.017%
8/12/2022	FMR LLC	5,846,060	$45.54M	0.0%	+1.7%	6.195%
8/11/2022	Healthcare of Ontario Pension Plan Trust Fund	616,900	$4.81M	0.0%	N/A	0.654%
8/11/2022	Bank of Montreal Can	153,799	$1.10M	0.0%	N/A	0.163%
8/11/2022	JPMorgan Chase & Co.	8,861,252	$69.03M	0.0%	+8.2%	9.391%

Data available starting January 2016

Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA2271 and ATA3271 to treat mesothelin; and ATA3219 for the treatment of B-cell malignancies, as well as ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center. The company was incorporated in 2012 and is headquartered in Thousand Oaks, California.

Today's Range

Now: $10.17

$9.67

$10.18

50 Day Range

MA: $11.61

$7.30

$17.75

52 Week Range

Now: $10.17

$4.96

$63.38

Volume

30,440 shs

Average Volume

95,650 shs

Market Capitalization

$49.02 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.52

Who are the company insiders with the largest holdings of Atara Biotherapeutics?: Atara Biotherapeutics' top insider shareholders include:
Pascal Touchon (CEO)
Anhco Nguyen (EVP)
Eric J Hyllengren (CFO)
Carol Giltner Gallagher (Director)
Jakob Dupont (EVP)
Amar Murugan (SVP)
Amar Murugan (EVP)
William K Heiden (Director)
Utpal Koppikar (CFO)
Learn More about top insider investors at Atara Biotherapeutics.